Fractional Laser as Treatment Option for Various Pigment Disorders (Fractional-3)

• Status: Completed
• Trial end date: 2010-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether the use of non-ablative fractional laser is safe and effective in the treatment of melasma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Netherlands Institute for Pigment Disorders
• Treatments: Triamcinolone Acetonide

Criteria

Inclusion Criteria:

• Melasma

• Subjects attending the outpatient department of the Netherlands Institute for Pigment Disorders

• Age at least 18 years

• Subject is willing and able to give written informed consent

Exclusion Criteria:

• use of bleaching creams during the past six weeks

• history of keloid

• active eczema

• suspected hypersensitivity to lidocaine or triple therapy

• use of isotretinoin in the past six months

• high exposure of the lesion to sunlight or UV light (UVA or UVB).